FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2765280537> ?p ?o ?g. }

• W2765280537 endingPage "58" @default.
• W2765280537 startingPage "51" @default.
• W2765280537 abstract "Abstract Objectives Here, we aimed to assess the pharmacokinetic performance and therapeutic response (anthelmintic efficacy) of an albendazole (ABZ) nano-sized formulation in dogs. Methods In the pharmacokinetic study, ABZ self-dispersible nanocrystals (SDNCS) and a control formulation were administered orally to healthy dogs (n = 6). The concentrations of the sulphoxide metabolite in plasma were determined by high-performance liquid chromatography. For the anthelmintic efficacy trial, SDNCS and a commercially available formulation of ABZ were given to naturally parasitised dogs. The number of Ancylostoma caninum eggs in the faeces was determined using the McMaster technique. Key findings The area under the curve, Tmax and Cmax for the SDNCS were improved compared to the control. The efficacy study showed no statistical differences between the SDNCS and the commercial formulation at the doses of 25 and 12.5 mg/kg. However, significant differences (P &lt; 0.05) between the treatments were found at 6.25 mg/kg (a quarter of the reference dose) with a reduction in the faecal nematode egg counts of 62.0 ± 21.1% and 100 ± 0% for the control and SDNCS, respectively. Conclusions The improved pharmacokinetic performance observed for the novel formulation of ABZ correlated with an improved in vivo therapeutic response against a model intestinal nematode parasite in dogs." @default.
• W2765280537 created "2017-11-10" @default.
• W2765280537 creator A5016282696 @default.
• W2765280537 creator A5031770091 @default.
• W2765280537 creator A5065954471 @default.
• W2765280537 creator A5066837527 @default.
• W2765280537 creator A5070773926 @default.
• W2765280537 creator A5071586306 @default.
• W2765280537 creator A5086266720 @default.
• W2765280537 date "2017-10-16" @default.
• W2765280537 modified "2023-10-16" @default.
• W2765280537 title "A nanocrystal-based formulation improves the pharmacokinetic performance and therapeutic response of albendazole in dogs" @default.
• W2765280537 cites W1584917795 @default.
• W2765280537 cites W1750459247 @default.
• W2765280537 cites W1971207761 @default.
• W2765280537 cites W1992552241 @default.
• W2765280537 cites W1994235150 @default.
• W2765280537 cites W1994951549 @default.
• W2765280537 cites W2000387844 @default.
• W2765280537 cites W2000924336 @default.
• W2765280537 cites W2008495939 @default.
• W2765280537 cites W2009697466 @default.
• W2765280537 cites W2013895677 @default.
• W2765280537 cites W2016971948 @default.
• W2765280537 cites W2019895773 @default.
• W2765280537 cites W2026750870 @default.
• W2765280537 cites W2026930707 @default.
• W2765280537 cites W2027238676 @default.
• W2765280537 cites W2034577655 @default.
• W2765280537 cites W2041317416 @default.
• W2765280537 cites W2062166509 @default.
• W2765280537 cites W2065769066 @default.
• W2765280537 cites W2076222842 @default.
• W2765280537 cites W2085700259 @default.
• W2765280537 cites W2092306308 @default.
• W2765280537 cites W2254658926 @default.
• W2765280537 cites W2319001629 @default.
• W2765280537 cites W2502670554 @default.
• W2765280537 cites W2582818666 @default.
• W2765280537 doi "https://doi.org/10.1111/jphp.12834" @default.
• W2765280537 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29034951" @default.
• W2765280537 hasPublicationYear "2017" @default.
• W2765280537 type Work @default.
• W2765280537 sameAs 2765280537 @default.
• W2765280537 citedByCount "17" @default.
• W2765280537 countsByYear W27652805372018 @default.
• W2765280537 countsByYear W27652805372019 @default.
• W2765280537 countsByYear W27652805372020 @default.
• W2765280537 countsByYear W27652805372021 @default.
• W2765280537 countsByYear W27652805372022 @default.
• W2765280537 crossrefType "journal-article" @default.
• W2765280537 hasAuthorship W2765280537A5016282696 @default.
• W2765280537 hasAuthorship W2765280537A5031770091 @default.
• W2765280537 hasAuthorship W2765280537A5065954471 @default.
• W2765280537 hasAuthorship W2765280537A5066837527 @default.
• W2765280537 hasAuthorship W2765280537A5070773926 @default.
• W2765280537 hasAuthorship W2765280537A5071586306 @default.
• W2765280537 hasAuthorship W2765280537A5086266720 @default.
• W2765280537 hasConcept C112705442 @default.
• W2765280537 hasConcept C126322002 @default.
• W2765280537 hasConcept C141071460 @default.
• W2765280537 hasConcept C149151106 @default.
• W2765280537 hasConcept C150903083 @default.
• W2765280537 hasConcept C165901193 @default.
• W2765280537 hasConcept C203014093 @default.
• W2765280537 hasConcept C207001950 @default.
• W2765280537 hasConcept C22979827 @default.
• W2765280537 hasConcept C2776908094 @default.
• W2765280537 hasConcept C2777065887 @default.
• W2765280537 hasConcept C2777477808 @default.
• W2765280537 hasConcept C2780406733 @default.
• W2765280537 hasConcept C42972112 @default.
• W2765280537 hasConcept C71924100 @default.
• W2765280537 hasConcept C86803240 @default.
• W2765280537 hasConcept C98274493 @default.
• W2765280537 hasConceptScore W2765280537C112705442 @default.
• W2765280537 hasConceptScore W2765280537C126322002 @default.
• W2765280537 hasConceptScore W2765280537C141071460 @default.
• W2765280537 hasConceptScore W2765280537C149151106 @default.
• W2765280537 hasConceptScore W2765280537C150903083 @default.
• W2765280537 hasConceptScore W2765280537C165901193 @default.
• W2765280537 hasConceptScore W2765280537C203014093 @default.
• W2765280537 hasConceptScore W2765280537C207001950 @default.
• W2765280537 hasConceptScore W2765280537C22979827 @default.
• W2765280537 hasConceptScore W2765280537C2776908094 @default.
• W2765280537 hasConceptScore W2765280537C2777065887 @default.
• W2765280537 hasConceptScore W2765280537C2777477808 @default.
• W2765280537 hasConceptScore W2765280537C2780406733 @default.
• W2765280537 hasConceptScore W2765280537C42972112 @default.
• W2765280537 hasConceptScore W2765280537C71924100 @default.
• W2765280537 hasConceptScore W2765280537C86803240 @default.
• W2765280537 hasConceptScore W2765280537C98274493 @default.
• W2765280537 hasFunder F4320311002 @default.
• W2765280537 hasFunder F4320312064 @default.
• W2765280537 hasFunder F4320321594 @default.
• W2765280537 hasFunder F4320323603 @default.
• W2765280537 hasFunder F4320323740 @default.
• W2765280537 hasIssue "1" @default.

• next